Konstan MW - Search Results

1

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations.

VanDevanter DR, O'Riordan MA, Blumer JL, Konstan MW. VanDevanter DR, et al. Among authors: konstan mw. Respir Res. 2010 Oct 6;11(1):137. doi: 10.1186/1465-9921-11-137. Respir Res. 2010. PMID: 20925941 Free PMC article.

2

Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects.

Konstan MW, Hoppel CL, Chai BL, Davis PB. Konstan MW, et al. J Pediatr. 1991 Jun;118(6):956-64. doi: 10.1016/s0022-3476(05)82218-8. J Pediatr. 1991. PMID: 2040934 Clinical Trial.

3

Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis.

Konstan MW, Vargo KM, Davis PB. Konstan MW, et al. Am Rev Respir Dis. 1990 Jan;141(1):186-92. doi: 10.1164/ajrccm/141.1.186. Am Rev Respir Dis. 1990. PMID: 2153353

4

Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Relation of clinical features to histopathologic patterns of pneumonia.

Tomashefski JF, Thomassen MJ, Bruce MC, Goldberg HI, Konstan MW, Stern RC. Tomashefski JF, et al. Among authors: konstan mw. Arch Pathol Lab Med. 1988 Feb;112(2):166-72. Arch Pathol Lab Med. 1988. PMID: 3337628

5

Effect of high-dose ibuprofen in patients with cystic fibrosis.

Konstan MW, Byard PJ, Hoppel CL, Davis PB. Konstan MW, et al. N Engl J Med. 1995 Mar 30;332(13):848-54. doi: 10.1056/NEJM199503303321303. N Engl J Med. 1995. PMID: 7503838 Free article. Clinical Trial.

6

Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.

Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Bonfield TL, et al. Among authors: konstan mw. Am J Respir Cell Mol Biol. 1995 Sep;13(3):257-61. doi: 10.1165/ajrcmb.13.3.7544594. Am J Respir Cell Mol Biol. 1995. PMID: 7544594

7

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Konstan MW, Hilliard KA, Norvell TM, Berger M. Konstan MW, et al. Am J Respir Crit Care Med. 1994 Aug;150(2):448-54. doi: 10.1164/ajrccm.150.2.8049828. Am J Respir Crit Care Med. 1994. PMID: 8049828

8

Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis.

Konstan MW, Walenga RW, Hilliard KA, Hilliard JB. Konstan MW, et al. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):896-901. doi: 10.1164/ajrccm/148.4_Pt_1.896. Am Rev Respir Dis. 1993. PMID: 8214945

9

Inflammatory cytokines in cystic fibrosis lungs.

Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Bonfield TL, et al. Among authors: konstan mw. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111-8. doi: 10.1164/ajrccm.152.6.8520783. Am J Respir Crit Care Med. 1995. PMID: 8520783

10

Cystic fibrosis.

Davis PB, Drumm M, Konstan MW. Davis PB, et al. Among authors: konstan mw. Am J Respir Crit Care Med. 1996 Nov;154(5):1229-56. doi: 10.1164/ajrccm.154.5.8912731. Am J Respir Crit Care Med. 1996. PMID: 8912731 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters